Skip to content

The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: An observational study

The efficacy of high-dose penicillin G for pneumococcal pneumonia diagnosed based on initial comprehensive assessment at admission: An observational study - The efficacy of high-dose penicillin G for pneumococcal pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025887
Enrollment
70
Registered
2017-01-28
Start date
2016-12-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Interventions

None listed

Sponsors

Tochigi Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The consecutive patients aged 18 years or older who were admitted to the hospital for pneumococcal pneumonia and who were initially treated with high-dose penicillin G (more than 1.2 million units of penicillin G).

Exclusion criteria

Exclusion criteria: Patients who were treated with high-dose penicillin G as a de-escalation therapy were excluded.

Design outcomes

Primary

MeasureTime frame
Clinical stability until day 6. Clinical stability was defined as a condition in which all the following threshold values were achieved for a 24-hour period: temperature of < 37.2, heart rate of < 100 beats/min, respiratory rate of < 24 breaths/min, systolic blood pressure of > 90 mmHg, and oxygen saturation of > 90% or arterial oxygen partial pressure of > 60 mmHg when the patient was not receiving supplemental oxygen.

Countries

Japan

Contacts

Public ContactJunpei Komagamine

Tochigi Medical Center Internal medicine

jkomagamine@tochigi-mc.jp028-622-5241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026